| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/28/2009 | CA2627903A1 Amphoteric microgels for the delivery of compounds to cells |
| 09/24/2009 | WO2009117616A2 Carbon nanotube compositions and methods of use thereof |
| 09/24/2009 | WO2009117418A2 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 09/24/2009 | WO2009117410A2 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques |
| 09/24/2009 | WO2009117333A1 Dithiocarbamate metal chelates and methods of making and using thereof |
| 09/24/2009 | WO2009117127A2 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | WO2009117057A1 Ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | WO2009117056A1 Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | WO2009117042A1 Use of pyrene to carry non-peptide agents across the blood brain barrier |
| 09/24/2009 | WO2009117041A2 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | WO2009116960A1 Pharmaceutical composition and a method for the production thereof |
| 09/24/2009 | WO2009116557A1 Drug-containing composition |
| 09/24/2009 | WO2009116556A1 Pharmaceutical composition for injection |
| 09/24/2009 | WO2009116509A1 Polymer conjugate of physiologically active substance |
| 09/24/2009 | WO2009116322A1 Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 09/24/2009 | WO2009116257A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | WO2009115531A2 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 09/24/2009 | WO2009115510A1 Antiviral formulation |
| 09/24/2009 | WO2009115175A2 Lyophilized nanoemulsion |
| 09/24/2009 | WO2009115053A1 Injectable sustained-release pharmaceutical formulation and the preparation method thereof |
| 09/24/2009 | WO2009114959A1 Injectalble sustained-release pharmaceutical formulation and method for preparing it |
| 09/24/2009 | WO2009094340A3 Omentum and use thereof |
| 09/24/2009 | WO2009063081A3 Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc. |
| 09/24/2009 | WO2009059755A3 Novel neurturin conjugates for pharmaceutical use |
| 09/24/2009 | WO2009052256A3 Bowel purgative and uses thereof |
| 09/24/2009 | WO2009048532A3 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 09/24/2009 | WO2009037061A3 Use of hydrophobin polypeptides as penetration enhancers |
| 09/24/2009 | WO2009026427A3 Liposome compositions for in vivo administration of boronic acid compounds |
| 09/24/2009 | WO2008143992A3 Improved depot formulations |
| 09/24/2009 | WO2007116409A4 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 09/24/2009 | US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/24/2009 | US20090239957 Stabilized glycerophosphate-containing surgical irrigating solution |
| 09/24/2009 | US20090239939 Combinations for introducing nucleic acids into cells |
| 09/24/2009 | US20090239836 Multifunctional Ophthalmic Compositions |
| 09/24/2009 | US20090239835 Stabilization of glucocorticoid esters with acids |
| 09/24/2009 | US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/24/2009 | US20090238907 Topical Compositions Containing Bacillus Coagulans Extracellular Products and Uses Thereof |
| 09/24/2009 | US20090238887 Highly Impact-Resistant Granules |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238882 Carbon-substituted diketopiperazine delivery systems |
| 09/24/2009 | US20090238881 Ionophore antibiotic formulations |
| 09/24/2009 | US20090238870 Dividable galenical form allowing modified release of the active ingredient |
| 09/24/2009 | US20090238865 Lipid nanocapsules, preparation process and use as medicine |
| 09/24/2009 | US20090238858 Compositions and Methods for Treating Ophthalmic Diseases |
| 09/24/2009 | US20090238857 Use of hydrophobic crosslinking agents to prepare crosslinked biomaterial compositions |
| 09/24/2009 | US20090238781 Polyglycerin-modified silicone and a cosmetic comprising the same |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/24/2009 | US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 09/24/2009 | DE102008015366A1 Lyophilisierte Nanoemulsion Lyophilized nanoemulsion |
| 09/24/2009 | CA2718915A1 Pharmaceutical composition and a method for the production thereof |
| 09/24/2009 | CA2718866A1 Ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | CA2718864A1 Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 09/24/2009 | CA2718860A1 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | CA2718791A1 Lyophilized nanoemulsion |
| 09/24/2009 | CA2718715A1 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | CA2718560A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | CA2718520A1 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 09/24/2009 | CA2717958A1 Dithiocarbamate metal chelates and methods of making and using thereof |
| 09/24/2009 | CA2717679A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 09/24/2009 | CA2717489A1 Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 09/24/2009 | CA2717440A1 Antiviral formulation |
| 09/24/2009 | CA2712511A1 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2103315A2 Sanitary napkins with hydrophobic lotions |
| 09/23/2009 | EP2103307A2 Methylphenidate Modified Release Formulations |
| 09/23/2009 | EP2103303A2 Controlled release formulation |
| 09/23/2009 | EP2102267A2 Polypeptides with the capacity to entrap drugs |
| 09/23/2009 | EP2102245A1 Polyvalent bioconjugates |
| 09/23/2009 | EP2101822A2 Use of peptides in combination with surgical intervention for the treatment of obesity |
| 09/23/2009 | EP2101821A1 Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life |
| 09/23/2009 | EP2101818A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 09/23/2009 | EP2101817A2 Human antibodies that bind cd19 and uses thereof |
| 09/23/2009 | EP2101779A1 Medical implants with a combination of compounds |
| 09/23/2009 | EP2101732A2 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 09/23/2009 | EP2101729A1 Self-microemulsifying drug delivery systems |
| 09/23/2009 | EP2101728A1 Dispersion of polyamino acids in a continuous lipid phase |
| 09/23/2009 | EP2101727A2 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid |
| 09/23/2009 | EP2101581A2 Veterinary formulation |
| 09/23/2009 | EP2101571A1 Non-standard amino acid conjugates of amphetamine and processes for making and using the same |
| 09/23/2009 | EP1420827B1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/23/2009 | EP1339418B1 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 09/23/2009 | EP1214944B1 Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity |
| 09/23/2009 | EP1044021B1 Enhanced transport using membrane disruptive agents |
| 09/23/2009 | CN101541347A Drug carriers, their synthesis, and methods of use thereof |
| 09/23/2009 | CN101541346A Formulations comprising cyclic compounds |
| 09/23/2009 | CN101538368A Copolymer with temperature/PH dual-sensibility and preparation and application thereof |
| 09/23/2009 | CN101538331A Single chain antibody-lidamycin fusion protein ER (Fv-LDP) targeting EGFR |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101538312A Preparation and applications of RGD-fatty amine series compound as tumor targeting vector material |
| 09/23/2009 | CN101538236A Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof |
| 09/23/2009 | CN101537209A Preparation process and application of three-dimensional network structure medical use hydrogel particles |
| 09/23/2009 | CN101537206A Application of nitrating multi-walled carbon nano-tube in preparation of biomedical materials |
| 09/23/2009 | CN101537191A Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN101537189A Aptamer and new use of derivative thereof |
| 09/23/2009 | CN101537188A Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound |
| 09/23/2009 | CN101537187A Anthocyanin phospholipids compound and preparation method thereof |
| 09/23/2009 | CN101537186A Vaccine freeze-drying protective agent without gelatin |
| 09/23/2009 | CN101537185A Tumor cell actively targeted drug delivery system, preparation method and application thereof |